Cargando…
Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
INTRODUCTION AND OBJECTIVES: Cardiovascular disease (CVD) is the leading cause of mortality worldwide and increased levels of low-density lipoprotein cholesterol (LDL-C) are an important modifiable risk factor. Statins lower LDL-C levels and have been shown to reduce CVD risk. Despite the widespread...
Autores principales: | Raal, Frederick J, Blom, Dirk J, Naidoo, Shanil, Bramlage, Peter, Brudi, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821092/ https://www.ncbi.nlm.nih.gov/pubmed/24240385 http://dx.doi.org/10.5830/CVJA-2013-071 |
Ejemplares similares
-
Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)
por: Devroey, D, et al.
Publicado: (2014) -
Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity
por: Moraba, Mpho, et al.
Publicado: (2013) -
Associations between body fat distribution, insulin resistance and dyslipidaemia in black and white South African women
por: Keswell, Dheshnie, et al.
Publicado: (2016) -
Interaction between dyslipidaemia, oxidative stress and inflammatory response in patients with angiographically proven coronary artery disease
por: Tayal, D, et al.
Publicado: (2012) -
Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
por: Al Sifri, Saud N., et al.
Publicado: (2014)